INPLASY202660065

FDG PET/CT in Drug-Induced Pulmonary and Systemic Toxicities: An Independent Systematic Review and Meta-Analysis of Metabolic Imaging for Immune-Related Adverse Event Surveillance, Drug-Induced Interstitial Lung Disease Risk Stratification, Sarcoid-Like Reaction Recognition, and Baseline Pneumonitis Risk Prediction from January 2000 Through May 2026

Keywords: PET/CT; FDG; immune checkpoint inhibitors; immune-related adverse events; irAE whole-body surveillance; bleomycin DIILD; radiomic risk stratification; thyroiditis; hypophysitis.

Review Status: ongoing